Concepedia
Statistics
Publications
4
Citations
138
H-Index
Active since
2009
Affiliations
Max Delbrück Center(Current)
University of Rostock
Charité - Universitätsmedizin Berlin
Joshua Alcaniz is an author at Max Delbrück Center specializing in medicine, pharmacology, and neuro-oncology.
Top concepts
GliomaHealthMedicineCell BiologyPharmacologyTumor BiologyCancer TherapyNeuro-oncologySystems BiologyDrug Development
Publications per year
2009–2024
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes
Sara Michel, Michael Linnebacher, Joshua Alcaniz et al. · International Journal of Cancer · 2009 · 64 citations · Full text
Integration of <i>ζ</i>-deficient CARs into the <i>CD3</i> <i>ζ</i> gene conveys potent cytotoxicity in T and NK cells
Jonas Kath, Clemens Franke, Vanessa Drosdek et al. · Blood · 2024 · 36 citations · Full text
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
Joshua Alcaniz, Lars Winkler, Mathias Dahlmann et al. · Frontiers in Oncology · 2023 · 22 citations · Full text
Chemoprevention Strategy, Gbm Models, High-grade Gliomas +21
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitors
Guus J.J.E. Heynen, Kamil Lisek, Regina Vogel et al. · Breast Cancer Research · 2022 · 16 citations · Full text
1–4 of 4